Christopher Bowden

2020

In 2020, Christopher Bowden earned a total compensation of $2.9M as Chief Medical Officer at Agios Pharmaceuticals, a 10% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$243,341
Option Awards$1,508,875
Salary$515,007
Stock Awards$618,120
Other$9,203
Total$2,894,546

Bowden received $1.5M in option awards, accounting for 52% of the total pay in 2020.

Bowden also received $243.3K in non-equity incentive plan, $515K in salary, $618.1K in stock awards and $9.2K in other compensation.

Rankings

In 2020, Christopher Bowden's compensation ranked 4,002nd out of 13,090 executives tracked by ExecPay. In other words, Bowden earned more than 69.4% of executives.

ClassificationRankingPercentile
All
4,002
out of 13,090
69th
Division
Manufacturing
1,612
out of 5,618
71st
Major group
Chemicals And Allied Products
613
out of 2,251
73rd
Industry group
Drugs
529
out of 1,951
73rd
Industry
Pharmaceutical Preparations
403
out of 1,456
72nd

Pay ratio

Christopher Bowden's Pay$2,894,546
Median Employee's Pay$253,211
Pay Ratio

11

to 1

In 2020, the annual total compensation of Christopher Bowden was $2,894,546.

The annual total compensation of the median employee at Agios Pharmaceuticals was $253,211.

The ratio of Christopher Bowden's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 8, 2021.

Bowden's colleagues

We found four more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2020.

2020

Jacqualyn Fouse

Agios Pharmaceuticals

Chief Executive Officer

2020

Bruce Car

Agios Pharmaceuticals

Chief Scientific Officer

2020

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2020

Jonathan Biller

Agios Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like